218 related articles for article (PubMed ID: 25859923)
1. Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.
Teh JL; Shah R; La Cava S; Dolfi SC; Mehta MS; Kongara S; Price S; Ganesan S; Reuhl KR; Hirshfield KM; Karantza V; Chen S
Breast Cancer Res Treat; 2015 May; 151(1):57-73. PubMed ID: 25859923
[TBL] [Abstract][Full Text] [Related]
2. Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
Martino JJ; Wall BA; Mastrantoni E; Wilimczyk BJ; La Cava SN; Degenhardt K; White E; Chen S
Oncogene; 2013 Sep; 32(37):4366-76. PubMed ID: 23085756
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
Speyer CL; Smith JS; Banda M; DeVries JA; Mekani T; Gorski DH
Breast Cancer Res Treat; 2012 Apr; 132(2):565-73. PubMed ID: 21681448
[TBL] [Abstract][Full Text] [Related]
4. Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.
Speyer CL; Nassar MA; Hachem AH; Bukhsh MA; Jafry WS; Khansa RM; Gorski DH
Breast Cancer Res Treat; 2016 Jun; 157(2):217-228. PubMed ID: 27146584
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
Namkoong J; Shin SS; Lee HJ; MarĂn YE; Wall BA; Goydos JS; Chen S
Cancer Res; 2007 Mar; 67(5):2298-305. PubMed ID: 17332361
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.
Shin SS; Namkoong J; Wall BA; Gleason R; Lee HJ; Chen S
Pigment Cell Melanoma Res; 2008 Jun; 21(3):368-78. PubMed ID: 18435704
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1
Shah R; Singh SJ; Eddy K; Filipp FV; Chen S
Cancer Res; 2019 Apr; 79(8):1799-1809. PubMed ID: 30987979
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Zhang C; Yuan XR; Li HY; Zhao ZJ; Liao YW; Wang XY; Su J; Sang SS; Liu Q
Cell Physiol Biochem; 2015; 35(2):419-32. PubMed ID: 25613036
[TBL] [Abstract][Full Text] [Related]
9. Functional effects of GRM1 suppression in human melanoma cells.
Wangari-Talbot J; Wall BA; Goydos JS; Chen S
Mol Cancer Res; 2012 Nov; 10(11):1440-50. PubMed ID: 22798429
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptor.
Teh JL; Shah R; Shin SS; Wen Y; Mehnert JM; Goydos J; Chen S
Pigment Cell Melanoma Res; 2014 Jul; 27(4):621-9. PubMed ID: 24628914
[TBL] [Abstract][Full Text] [Related]
11. AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).
Shin SS; Wall BA; Goydos JS; Chen S
Pigment Cell Melanoma Res; 2010 Feb; 23(1):103-11. PubMed ID: 19843246
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mGluR1 expression in human melanocytes and melanoma cells.
Lee HJ; Wall BA; Wangari-Talbot J; Chen S
Biochim Biophys Acta; 2012; 1819(11-12):1123-31. PubMed ID: 22771868
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.
Banda M; Speyer CL; Semma SN; Osuala KO; Kounalakis N; Torres Torres KE; Barnard NJ; Kim HJ; Sloane BF; Miller FR; Goydos JS; Gorski DH
PLoS One; 2014; 9(1):e81126. PubMed ID: 24404125
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic signaling in cellular transformation.
Teh JL; Chen S
Pigment Cell Melanoma Res; 2012 May; 25(3):331-42. PubMed ID: 22273393
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer.
Speyer CL; Hachem AH; Assi AA; Johnson JS; DeVries JA; Gorski DH
PLoS One; 2014; 9(3):e88830. PubMed ID: 24633367
[TBL] [Abstract][Full Text] [Related]
16. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis.
Liu Y; Chen N; Cui X; Zheng X; Deng L; Price S; Karantza V; Minden A
Oncogene; 2010 Nov; 29(44):5883-94. PubMed ID: 20697354
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer.
Sexton RE; Hachem AH; Assi AA; Bukhsh MA; Gorski DH; Speyer CL
Sci Rep; 2018 Oct; 8(1):16008. PubMed ID: 30375476
[TBL] [Abstract][Full Text] [Related]
18. LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
Duong MT; Akli S; Wei C; Wingate HF; Liu W; Lu Y; Yi M; Mills GB; Hunt KK; Keyomarsi K
PLoS Genet; 2012; 8(3):e1002538. PubMed ID: 22479189
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.
Mehta MS; Dolfi SC; Bronfenbrener R; Bilal E; Chen C; Moore D; Lin Y; Rahim H; Aisner S; Kersellius RD; Teh J; Chen S; Toppmeyer DL; Medina DJ; Ganesan S; Vazquez A; Hirshfield KM
PLoS One; 2013; 8(7):e69851. PubMed ID: 23922822
[TBL] [Abstract][Full Text] [Related]
20. Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
Wen Y; Li J; Koo J; Shin SS; Lin Y; Jeong BS; Mehnert JM; Chen S; Cohen-Sola KA; Goydos JS
Cancer Res; 2014 May; 74(9):2499-509. PubMed ID: 24491800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]